Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Hot Flashes 2Breast Neoplasms 2

Interventions

Cyclophosphamide 517Bevacizumab 488Carboplatin 424pembrolizumab 388Paclitaxel 385Gemcitabine 372Cisplatin 366Docetaxel 323Rituximab 316Radiotherapy 296Nivolumab 247Doxorubicin 243Dexamethasone 240Fluorouracil 225Capecitabine 214Oxaliplatin 211Erlotinib Hydrochloride 206fludarabine phosphate 201Etoposide 188Cetuximab 186Lenalidomide 177Pemetrexed 176Bortezomib 174Trastuzumab 173Filgrastim 171fludarabine 166Prednisone 166Leucovorin 166Cytarabine 166Irinotecan 161

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Has results × Magnesium Oxide × Clear all
NCT01439945 2017-04-04

Magnesium Oxide in Treating Postmenopausal Women With Hot Flashes and a History of Breast Cancer

Alliance for Clinical Trials in Oncology

Phase 2 Completed
289 enrolled 13 charts
Breast

Breast Neoplasms, Hot Flashes

NCT01008904 2016-06-21

Magnesium Oxide in Treating Hot Flashes in Menopausal Women With Cancer

Virginia Commonwealth University

Phase 2 Completed
31 enrolled 8 charts
Breast

Breast Neoplasms, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡